Will Lewis, President and Chief Executive Officer of Insmed, will be presenting a corporate overview at the 12th Annual Needham Healthcare Conference taking place at the Westin Grand Central in New York City from April 30-May 1, 2013. Mr. Lewis' presentation will take place at 3:00 p.m. on April 30th.
Two Near-Term Commercial Opportunities in Orphan Lung Diseases
● Europe: ARIKACE phase 3 trial in CF patients; enrollment completed; data mid-2013
● US: ARIKACE phase 2 trial in NTM patients enrolling; data year-end 2013
Solid and Broad IP Portfolio
● Decade+ of investment in research and development
● Potential coverage into 2029
"As we near data readouts for both our phase 3 clinical trial in CF and our phase 2 clinical trial in NTM, we are expanding our senior leadership with experienced executives with proven track records of consistently superior performance. With his results-driven background and market knowledge, Matt surely will be a valuable asset to our team.".....
Will Lewis a few weeks ago.... The near is closer!